Evidence map›Paper›PMID 38391939›Full record

ArticleCells2024

Human RPF1 and ESF1 in Pre-rRNA Processing and the Assembly of Pre-Ribosomal Particles: A Functional Study.

Alexander Deryabin, Anastasiia Moraleva, Kira Dobrochaeva, Diana Kovaleva, Maria Rubtsova, Olga Dontsova, Yury Rubtsov

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cells, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. RiboScreenBiomedicines · 2026
    Review
  2. Article
  3. An improved cell nuclear isolation method.Biology methods & protocols · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Alexander DeryabinShemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS, 119997 Moscow, Russia.ORCID 0000-0001-9129-6051
Anastasiia MoralevaShemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS, 119997 Moscow, Russia.
Kira DobrochaevaShemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS, 119997 Moscow, Russia.ORCID 0000-0002-4778-344X
Diana KovalevaShemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS, 119997 Moscow, Russia.
Maria RubtsovaDepartment of Chemistry, Lomonosov Moscow State University, 119991 Moscow, Russia.
Olga DontsovaShemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS, 119997 Moscow, Russia.
Yury RubtsovShemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS, 119997 Moscow, Russia.ORCID 0000-0001-9175-3013
Institute of Bioorganic Chemistry · RULomonosov Moscow State University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ribosome biogenesis is essential for the functioning of living cells. In higher eukaryotes, this multistep process is tightly controlled and involves a variety of specialized proteins and RNAs. This pool of so-called ribosome biogenesis factors includes diverse proteins with enzymatic and structural functions. Some of them have homologs in yeast

Indexed as

RNA-Binding ProteinsRNA PrecursorsHEK293 CellsHumansRibosomesRNA-Binding ProteinsRNA Precursorsnucleolusribosomal RNA processingribosome biogenesis

Identifiers

PMID38391939
PMCPMC10886481
OpenAlexW4391753002

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.